Inari Agriculture
720 million cumulative funding; SEEDesign™ platform combines multiplex CRISPR-CasS editing with AI predictive design; soybeans first to market targeting +10–20% yield and -40% nitrogen use.
- Country
- United States
CRISPR
US
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| crop-biotech | ✓ | ✓ | ✓ | ✓ |
Regulatorsusda-aphisefsamoa-china
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Precision Plant Breeding & CRISPR Crop Editing | crop-biotech | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.